108 results

• Wegovy Lawsuit Alleges Vision Loss Side Effects Concealed by Novo Nordisk

  May 6, 2025

  Irvin Jackson

  A Wegovy lawsuit claims the weight loss drug's side effects caused him to suffer vision problems after a year of injections.

• Gastric Bypass More Effective Than Sleeves, But May Carry Hypoglycemia Risks: Study

  April 30, 2025

  Martha Garcia

  A new study finds that gastric bypass surgery is more effective at causing weight loss and type 2 diabetes remission than gastric sleeve surgery, but at the cost of potentially dangerous low blood sugar levels.

• Ozempic Blindness Lawsuit Claims Drug Caused NAION Side Effects

  April 28, 2025

  Irvin Jackson

  A new lawsuit claims that the diabetes and weight loss drug, Ozempic, caused a woman to lose vision in her left eye.

• Ozempic Side Effects Caused Stomach Paralysis and Severe Abdominal Pain, Lawsuit Claims

  April 18, 2025

  Irvin Jackson

  A product liability lawsuit filed against Novo Nordisk accuses the drug maker of failing to provide adequate warnings of Ozempic side effects, like stomach paralysis.

• Ozempic Gastroparesis Lawsuit Filed Over Nausea, Severe Abdominal Pain

  April 4, 2025

  Irvin Jackson

  Following three years of Ozempic injections, an Oklahoma woman had to stop using the diabetes drug due to gastroparesis side effects.

• Ozempic Delayed Gastric Emptying Led to Stomach Paralysis: Lawsuit

  March 27, 2025

  Irvin Jackson

  A Mississippi woman’s Ozempic lawsuit indicates that she suffered stomach paralysis due to the drug's delayed gastric emptying side effects, which left her with permanent injuries.

• Court Urged To Reject Motion To Dismiss Lawsuits Over Ozempic, Mounjaro Gastrointestinal Risks

  March 21, 2025

  Irvin Jackson

  Pushing back against a motion to dismiss, plaintiffs involved in GLP-1 lawsuits say GLP-1 manufacturers intentionally misled the medical community and patients regarding the safety of the diabetes and weight loss drugs.

• GLP-1 Manufacturers Argue Gastroparesis Lawsuits Should Require Contemporaneous Diagnostic Testing

  March 17, 2025

  Irvin Jackson

  Eli Lilly has filed a motion calling for a federal judge to put in place specific requirements for establishing a gastroparesis diagnosis in stomach paralysis lawsuits filed against the makers of Mounjaro, Ozempic and other GLP-1 medications.

• Study Suggests There May Not Be a Link Between Ozempic, Mounjaro and Post-Surgery Aspiration Pneumonia

  March 12, 2025

  Irvin Jackson

  New findings appear to contradict warnings that GLP-1 drugs, like Ozempic and Mounjaro, can increase the risk of post-surgical aspiration due to a lack of gastric emptying.

• Ozempic Hair Loss Side Effects Doubled for Users, Study Finds

  March 7, 2025

  Irvin Jackson

  The findings of a new study indicate that Ozempic and Wegovy use can double the risk of hair loss, in part due to stress from rapid weight loss.